Recent Finacing
Recent Raise
Synageva BioPharma is a biopharmaceutical company developing SEP-based protein therapeutics and enzyme replacement therapies for rare lysosomal disorders, conducting global clinical studies and scaling commercial manufacturing and physician networks.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor